TruTrace Technologies (CSE:TTT, OTC:BKKSF) was recently featured in an article by Coindesk regarding the company’s new partnership with TheraCann, an international cannabis consultancy and technology company. The Panamanian company is interested in adding forensic traceability to the cannabis industry through TruTrace’s industry blockchain hub. Under the terms of the agreement, TruTrace and TheraCann are expected to explore opportunities to combine TruTrace’s StrainSecure™ technology with Theracann’s ETCH biotrace™ genetic tracking system for cannabis and hemp.

“Creating an eco-system of technologies with the intent to provide patients, government, and the industry with supply chain integrity, true IP protection and analytical testing and validation is an important next step for the cannabis and hemp industry evolution,” said Robert Galarza, CEO of TruTrace Technologies. “We are excited to connect Theracann’s ETCH molecular track and trace system with StrainSecure and to explore additional opportunities for collaboration between our organizations.”


TruTrace is working to establish partnerships with industry leaders and complementary technology companies. The company has recently announced a pilot program with Canada’s largest pharmacy chain, Shoppers Drug Mart, to develop a central hub for identifying, tracking and validating products.

To read the full article from Coindesk, click here.

Click here to connect with TruTrace Technologies (CSE:TTT;OTC:BKKSF) for an Investor Presentation.

Two US-based multi-state operators (MSOs) added fuel to the ongoing merger and acquisition (M&A) train currently making its way across the cannabis sector.

On the flip side, one of Canada’s biggest cannabis producers told the market this week that it has no interest in further acquisitions in the Canadian market.

Keep reading... Show less

 Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”), a wellness company that makes and sells plant-based products, is ramping up production at its Victoria, BC production facility to fulfill incoming orders from seven Whole Foods Market in Ontario, Canada (“Whole Foods”).

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/84022_947985ee845d7afb_001.jpg

Keep reading... Show less
  • Domestic Medical Net Revenue Steady at $26.9 Million
  • Strong International Medical Net Revenue of $9.4 Million
  • Total Cannabis Net Revenue, Excluding Provisions, of $58.4 Million
  • Business Transformation Plan Continues, Management Expects to Deliver Incremental Cost-Saving Measures of $60 Million to $80 Million Annually
  • Balance Sheet Remains Strong with ~$525 Million of Cash on Hand at May 12, 2021
  • Lead Independent Director Ronald Funk Appointed as Chairman, Michael Singer to Remain Board Member

NYSE | TSX: ACB

 Aurora Cannabis Inc. (the ” Company ” or ” Aurora “) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the third quarter of fiscal 2021 ended March 31, 2021 .

Keep reading... Show less

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies

Keep reading... Show less

Experienced executives fill senior roles in business development, M&A, clinic operations and design, and corporate communications

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced the appointments of five experienced leaders to support strategic growth initiatives across the Company’s three divisions Numinus Health, Numinus R&D and Numinus Bioscience.

Keep reading... Show less